Physician profile
Kusum Lata
NPI 1477884161
$5,729.28
in general payments reported to CMS, 2019-2025
32 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $201 · 2021: $220 · 2022: $836 · 2023: $494 · 2024: $536 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,143.51 | 2019-2025 | General - Therapies, Cds - Mct/Cem Monitoring, Avvigo Guidance System |
| Corindus INC. | $1,045.41 | 2019 | |
| Abbott Laboratories | $385.53 | 2019-2023 | Mitraclip, Diamondback Peripheral |
| Shockwave Medical, INC | $312.78 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $312.24 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $297.51 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $269.56 | 2022 | |
| Philips North America LLC | $243.08 | 2020-2025 | (5044) Mcot, Mcot, Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $218.60 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $189.75 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $188.64 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.52 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $159.32 | 2019-2025 | |
| Abiomed | $146.08 | 2019-2025 | |
| Pfizer INC. | $118.42 | 2019-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $73.22 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $70.12 | 2024-2025 | Farxiga |
| Baxter Healthcare | $40.60 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $35.72 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $33.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.57 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $32.40 | 2019 | |
| Cook Medical LLC | $27.04 | 2019 | |
| Genentech USA, INC. | $24.32 | 2019 | |
| Shire North American Group INC | $22.08 | 2019 | |
| Gilead Sciences, INC. | $21.76 | 2019 | |
| Vifor Pharma, INC. | $21.03 | 2019 | |
| Portola Pharmaceuticals, LLC | $20.95 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2021 | |
| Atricure, INC. | $17.16 | 2023 | |
| Amarin Pharma, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kusum Lata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.